Synonyms: | |
Status: | Approved (2003) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | C10AA07 |
UNII: | 413KH5ZJ73 |
InChI Key | BPRHUIZQVSMCRT-VEUZHWNKSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C22H28FN3O6S |
Molecular Weight | 481.55 |
AlogP | 2.4 |
Hydrogen Bond Acceptor | 7.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 10.0 |
Polar Surface Area | 140.92 |
Molecular species | ACID |
Aromatic Rings | 2.0 |
Heavy Atoms | 33.0 |
Primary Target | |
---|---|
hydroxymethylglutaryl-CoA reductase |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | 2-4 | 17 | 1-71000 | - | |
Enzyme
Phosphodiesterase
Phosphodiesterase 6
Phosphodiesterase 6D
|
- | - | 1250 | - | - | |
Enzyme
Protease
Serine protease
Serine protease SC clan
Serine protease S9B subfamily
|
- | - | - | - | 4 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 51 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Acute Coronary Syndrome | 3 | D054058 | ClinicalTrials |
Heart Failure | 3 | D006333 | ClinicalTrials |
Hyperlipidemias | 3 | D006949 | ClinicalTrials |
Atherosclerosis | 3 | D050197 | ClinicalTrials |
Hip Fractures | 3 | D006620 | ClinicalTrials |
Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3 | D056648 | ClinicalTrials |
Coronary Artery Disease | 3 | D003324 | ClinicalTrials |
Aortic Valve Stenosis | 3 | D001024 | ClinicalTrials |
Cardiomyopathy, Dilated | 3 | D002311 | ClinicalTrials |
Hypertension | 3 | D006973 | ClinicalTrials |
Renal Insufficiency | 3 | D051437 | ClinicalTrials |
HIV Infections | 3 | D015658 | ClinicalTrials |
Renal Insufficiency | 3 | D051437 | ClinicalTrials |
Necrosis | 3 | D009336 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Hyperlipoproteinemia Type III | 3 | D006952 | ClinicalTrials |
Metabolic Syndrome | 3 | D024821 | ClinicalTrials |
Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
Stroke | 3 | D020521 | ClinicalTrials |
Scleroderma, Systemic | 3 | D012595 | ClinicalTrials |
HIV Infections | 3 | D015658 | ClinicalTrials |
Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
Obesity | 3 | D009765 | ClinicalTrials |
Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
Coronary Disease | 3 | D003327 | ClinicalTrials |
Heart Failure | 3 | D006333 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Myocardial Infarction | 2 | D009203 | ClinicalTrials |
Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
Diabetes Mellitus | 2 | D003920 | ClinicalTrials |
Ischemia | 2 | D007511 | ClinicalTrials |
Periodontitis | 2 | D010518 | ClinicalTrials |
Pre-Eclampsia | 2 | D011225 | ClinicalTrials |
Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
Hepatitis C | 2 | D006526 | ClinicalTrials |
Venous Thromboembolism | 2 | D054556 | ClinicalTrials |
Orthomyxoviridae Infections | 2 | D009976 | ClinicalTrials |
Cerebral Hemorrhage | 2 | D002543 | ClinicalTrials |
Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
Amnesia | 2 | D000647 | ClinicalTrials |
Sepsis | 2 | D018805 | ClinicalTrials |
Burns | 2 | D002056 | ClinicalTrials |
Renal Artery Obstruction | 2 | D012078 | ClinicalTrials |
Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Tuberculosis, Pulmonary | 2 | D014397 | ClinicalTrials |
Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
Depressive Disorder | 2 | D003866 | ClinicalTrials |
Endometrial Hyperplasia | 2 | D004714 | ClinicalTrials |
Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
Angioedemas, Hereditary | 1 | D054179 | ClinicalTrials |
Parkinson Disease | 1 | D010300 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Craniocerebral Trauma | 1 | D006259 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
Crohn Disease | 1 | D003424 | ClinicalTrials |
Anemia | 1 | D000740 | ClinicalTrials |
Hypertriglyceridemia | 1 | D015228 | ClinicalTrials |
Metabolic Diseases | 1 | D008659 | ClinicalTrials |
Immune System Diseases | 1 | D007154 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Non-alcoholic Fatty Liver Disease | 1 | D065626 | ClinicalTrials |
Respiratory Syncytial Virus Infections | 1 | D018357 | ClinicalTrials |
Lupus Erythematosus, Systemic | 1 | D008180 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
Asthma | 1 | D001249 | ClinicalTrials |
Malaria | 1 | D008288 | ClinicalTrials |
Skin Diseases | 1 | D012871 | ClinicalTrials |
Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
Friedreich Ataxia | 0 | D005621 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 287714-41-4 |
ChEBI | 38545 |
ChEMBL | CHEMBL1496 |
DrugBank | DB01098 |
DrugCentral | 2406 |
EPA CompTox | DTXSID8048492 |
FDA SRS | 413KH5ZJ73 |
Human Metabolome Database | HMDB0015230 |
Guide to Pharmacology | 2954 |
PubChem | 446157 |
SureChEMBL | SCHEMBL2520 |
ZINC | ZINC000001535101 |